Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00735
|
|||||
| Drug Name |
MGCD-0103
|
|||||
| Synonyms |
MG 0103; MG 4230; MG 4915; MG 5026; MG-0103; MG-4230; MG-4915; MG-5026; MG0103; MG4230; MG4915; MG5206; MGCD 0103; MGCD0103; Mocetinostat; Mocetinostat, MGCD0103; N-(2-Aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide; N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Anticancer Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C23H20N6O
|
|||||
| Canonical SMILES |
C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4
|
|||||
| InChI |
InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)
|
|||||
| InChIKey |
HRNLUBSXIHFDHP-UHFFFAOYSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 396.4 | Topological Polar Surface Area | 106 | ||
| Heavy Atom Count | 30 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
2.8
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.